Valuation: Healius Limited

Market Cap 254M 177M 156M 145M 133M 250M 17.16B 1.73B 675M 8.37B 665M 651M 29.03B P/E 2026 *
-9.21x
P/E 2027 * -97.8x
Enterprise Value 1.16B 810M 712M 662M 609M 1.14B 78.44B 7.91B 3.09B 38.26B 3.04B 2.97B 133B EV / Sales 2026 *
0.84x
EV / Sales 2027 * 0.83x
Free-Float
77.51%
Yield 2026 *
-
Yield 2027 * 0.38%
1 day-1.41%
1 week-10.26%
Current month-10.26%
1 month-6.67%
3 months-34.58%
6 months-62.77%
Current year-61.33%
1 week 0.34
Extreme 0.34
0.4
1 month 0.34
Extreme 0.34
0.4
Current year 0.3
Extreme 0.3
1.05
1 year 0.3
Extreme 0.3
1.07
3 years 0.3
Extreme 0.3
3.05
5 years 0.3
Extreme 0.3
5.54
10 years 0.3
Extreme 0.3
5.54
Manager TitleAgeSince
Chief Executive Officer - 2024-03-04
Director of Finance/CFO - 2025-10-12
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 2018-08-20
Chairman 65 2023-11-27
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
6/29/26 Expiration

Chief Executive Officer

-75,887 0.0105%
4/22/26 Fiscal year

Director

22,978 0.0032%
3/13/26 Buy

Director

8,547 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
-1.41%-10.26%-54.55%-87.68% 180M
+0.18%-1.90%+92.05%+465.70% 37.84B
+3.40%+3.22%+16.17%+33.00% 23.08B
0.00%-3.17%-24.50%-41.14% 7.19B
+2.97%-3.19%+4.17%+76.91% 4.66B
-0.70%-2.10%+12.32%+47.54% 2.94B
+1.64%-4.04%+115.43%-14.78% 1.82B
+1.25%+2.74%-23.59%+714.65% 1.86B
-2.18%-5.42%-8.99%-62.78% 1.85B
+7.66%+0.97%+14.27%+5.81% 1.79B
Average +1.28%-2.57%+14.28%+113.72% 8.32B
Weighted average by Cap. +1.34%-1.90%+46.89%+237.52%

Financials

2026 *2027 *
Net sales 1.38B 961M 845M 785M 722M 1.35B 93.05B 9.39B 3.66B 45.39B 3.61B 3.53B 157B 1.42B 990M 871M 809M 744M 1.4B 95.87B 9.67B 3.77B 46.76B 3.72B 3.64B 162B
Net income -27.45M -19.13M -16.83M -15.63M -14.38M -26.96M -1.85B -187M -72.92M -904M -71.83M -70.28M -3.14B -447K -312K -274K -255K -234K -440K -30.21M -3.05M -1.19M -14.73M -1.17M -1.15M -51.11M
Net Debt 908M 633M 557M 517M 476M 892M 61.28B 6.18B 2.41B 29.89B 2.38B 2.32B 104B 930M 648M 570M 530M 487M 913M 62.76B 6.33B 2.47B 30.61B 2.43B 2.38B 106B
Logo Healius Limited
Healius Limited is a healthcare company. The Company's specialized pathology businesses deliver healthcare services across Australia. It provides pathology services, including specialty pathology and clinical trials. It offers medical laboratory and pathology services through a variety of specialty brands. It provides medical laboratory and pathology services across key diagnostic activities. These include anatomical pathology (histopathology and cytology), clinical pathology (biochemistry, hematology, immunology and microbiology), genomic diagnostics and veterinary pathology. Its brands include Abbot, Agilex Biolabs, Dorevitch, Gastrolab, Genomic Diagnostics, IQ Pathology, Kossard Dermatopathology, Laverty Pathology, QML Pathology, TML Pathology, Vetnostics Pathology and Western Diagnostic Pathology (WDP). These brands operate in Queensland, New South Wales (including the Australian Capital Territory), Victoria, Western Australia and Northern Territory, Tasmania, and South Australia.
Employees
5,962
Date Price Change Volume
26-07-23 A$0.3500 -1.41% 2,561,596
26-07-22 A$0.3550 -1.39% 1,828,874
26-07-21 A$0.3600 0.00% 2,699,905
26-07-20 A$0.3600 -4.00% 4,665,537
26-07-17 A$0.3750 -6.25% 2,435,823
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
10
Last Close Price
0.3500AUD
Average target price
0.4962AUD
Spread / Average Target
+41.77%

Quarterly revenue - Rate of surprise